Literature DB >> 19038623

How does lowering of intraocular pressure protect the optic nerve?

Paul Mackenzie1, George Cioffi.   

Abstract

Until recently, the evidence that lowering intraocular pressure (IOP) protects the optic nerve from glaucomatous damage was weak. Several randomized controlled trials have provided stronger evidence that lowering IOP prevents glaucomatous progression. Optic nerves appear to be highly variable in their susceptibility to raised IOP. Elevated IOP likely triggers several parallel, but interacting mechanisms, including direct axonal damage, failure of load-bearing tissues, and disturbances in microvascular supply. The cellular mechanisms that translate these mechanical and physiologic stresses and that lead to excavation of optic nerve tissue are beginning to be understood.

Entities:  

Mesh:

Year:  2008        PMID: 19038623     DOI: 10.1016/j.survophthal.2008.08.008

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  14 in total

1.  Effect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells.

Authors:  Charanya Ramachandran; Rajkumar V Patil; Najam A Sharif; Sangly P Srinivas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

2.  Diffusion tensor imaging detects retinal ganglion cell axon damage in the mouse model of optic nerve crush.

Authors:  Xu Zhang; Peng Sun; Jian Wang; Qing Wang; Sheng-Kwei Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

3.  Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice.

Authors:  Lambros Panagis; Xiujun Zhao; Yongchao Ge; Lizhen Ren; Thomas W Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-03       Impact factor: 4.799

4.  Effect of hevin deletion in mice and characterization in trabecular meshwork.

Authors:  Min Hyung Kang; Dong-Jin Oh; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

Review 5.  Glaucoma: recent advances in the involvement of autoimmunity.

Authors:  Maria Ida Rizzo; Antonio Greco; Armando De Virgilio; Andrea Gallo; Luciano Taverniti; Massimo Fusconi; Michela Conte; Giulio Pagliuca; Rosaria Turchetta; Marco de Vincentiis
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

6.  Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage.

Authors:  Xin Wei; Zhanyang Yu; Kin-Sang Cho; Huihui Chen; Muhammad Taimur A Malik; Xiaoming Chen; Eng H Lo; Xiaoying Wang; Dong F Chen
Journal:  Am J Pathol       Date:  2011-10-01       Impact factor: 4.307

7.  An hypothesis on pressure transmission from anterior chamber to optic nerve.

Authors:  Rosana Gerometta; D Escobar; Oscar A Candia
Journal:  Med Hypotheses       Date:  2011-08-19       Impact factor: 1.538

Review 8.  Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension.

Authors:  Zerin Alimajstorovic; Connar S J Westgate; Rigmor H Jensen; Sajedeh Eftekhari; James Mitchell; Vivek Vijay; Senali Y Seneviratne; Susan P Mollan; Alexandra J Sinclair
Journal:  Eye (Lond)       Date:  2020-01-02       Impact factor: 3.775

9.  Head-up tilt lowers IOP and improves RGC dysfunction in glaucomatous DBA/2J mice.

Authors:  Vittorio Porciatti; Mahesh Nagaraju
Journal:  Exp Eye Res       Date:  2009-12-29       Impact factor: 3.467

10.  Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.

Authors:  Scott D Smid
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.